Vanguard Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $313M | Buy |
|
|||||
|
2022
Q1 | $105M | Buy |
|
|||||
|
2021
Q4 | $185M | Buy |
|
|||||
|
2021
Q3 | $257M | Buy |
|
|||||
|
2021
Q2 | $289M | Buy |
|
|||||
|
2021
Q1 | $349M | Buy |
|
|||||
|
2020
Q4 | $419M | Buy |
|
|||||
|
2020
Q3 | $251M | Buy |
|
|||||
|
2020
Q2 | $180M | Buy |
|
|||||
|
2020
Q1 | $93.3M | Buy |
|
|||||
|
2019
Q4 | $122M | Buy |
|
|||||
|
2019
Q3 | $27.2M | Buy |
|
|||||
|
2019
Q2 | $17.7M | Buy |
|